Savara Inc
SVRA Nasdaq· Pharmaceutical Preparations
Last close · Oct 23, 2026
$4.22
KIRA · Stoqly’s AI analyst, in plain words
- Savara Inc lost $119M in fiscal 2025.
- Free cash flow was −$101M in fiscal 2025, — of revenue.
- Savara Inc has $206M more cash than debt.
Market cap
$1.1B
P/E
—
Revenue
—
Net income
−$119M
Free cash flow
−$101M
Operating margin
—
Savara Inc in 30 seconds · fiscal 2025
Does it make a profit?
−$119M
No. It lost money last year.
How healthy are the accounts?
2 / 7
Weak. It passes 2 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Savara Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 13, 2026
- Legal name
- Savara Inc
- CIK
- 0001160308
Savara Inc · SVRA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$43.0M | −$38.2M | −$54.7M | −$95.9M | −$119M |
| Diluted EPS | −$0.32 | −$0.25 | −$0.33 | −$0.48 | −$0.53 |
| Cash | |||||
| Cash from operations | −$40.1M | −$34.6M | −$51.1M | −$89.1M | −$101M |
| Capital expenditure | $0.1M | $0.0M | $0.3M | $0.0M | $0.0M |
| Free cash flow | −$40.1M | −$34.6M | −$51.4M | −$89.1M | −$101M |
| Share count change | 125.8% | 14.1% | 8.1% | 20.0% | 12.2% |
| Debt and strength | |||||
| Cash and short-term investments | $161M | $126M | $162M | $196M | $236M |
| Debt incl. finance leases | $25.7M | $26.1M | $26.3M | $26.6M | $29.9M |
| Shareholders' equity | $144M | $108M | $140M | $171M | $203M |
| Current ratio | 11.3x | 22.0x | 15.7x | 13.7x | 11.8x |
| Returns and quality | |||||
| Return on capital | −364.8% | −384.5% | −1,077.2% | −4,682.6% | — |
| Return on equity | −41.2% | −30.2% | −44.1% | −61.5% | −63.5% |
| Return on tangible equity | −29.8% | −35.4% | −39.0% | −55.9% | −58.5% |
| Piotroski F-score | 4 | 2 | 2 | 2 | 2 |
| Altman Z'' | 3.2 | −0.5 | 0.2 | −0.6 | −1.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$2.4M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Savara Inc · SVRA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $4.22 a share, the company is worth $1.1B.
Source: SEC EDGAR XBRL filings (CIK 0001160308). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.